ConductScience.org, home

Paper24674015

Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Li JX and 7 others. Radiat Oncol, 2014. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy. Papers, record 24674015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24674015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
PubMed
Journal
Radiat Oncol
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.08
iCite
Revised in PubMed
2022-03-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li JXJia-Xin
2Huang SMShao-min
3Jiang XHXin-hua
4Ouyang BBin
5Han FFei
6Liu SShuai
7Wen BXBi-xiu
8Lu TXTai-xiang

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Nasopharyngeal NeoplasmsMajor topic
Neoplasm Recurrence, LocalMajor topic
Radiotherapy, Intensity-ModulatedMajor topic
Adult
Aged
Carcinoma
Female
Follow-Up Studies
Humans
Magnetic Resonance Spectroscopy
Male
Middle Aged
Nasopharyngeal Carcinoma
Neoplasm Invasiveness
Radiotherapy Dosage
Treatment Failure
Tumor Burden
Young Adult

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119564532Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.J Clin Oncol2009https://conductscience.org/library/papers/19564532PubMed
29510041
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
Radiother Oncol1998https://conductscience.org/library/papers/9510041PubMed
316626829Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).Radiother Oncol2006https://conductscience.org/library/papers/16626829PubMed
417869020Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.Int J Radiat Oncol Biol Phys2008https://conductscience.org/library/papers/17869020PubMed
515752890Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15752890PubMed
617869667Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17869667PubMed
77620219Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.Oncol Res1994https://conductscience.org/library/papers/7620219PubMed
812527043Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.Int J Radiat Oncol Biol Phys2003https://conductscience.org/library/papers/12527043PubMed
919386431Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.Int J Radiat Oncol Biol Phys2009https://conductscience.org/library/papers/19386431PubMed
1012007936Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.Int J Radiat Oncol Biol Phys2002https://conductscience.org/library/papers/12007936PubMed
1122178121Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.Lancet Oncol2012https://conductscience.org/library/papers/22178121PubMed
122293704Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients.Laryngoscope1990https://conductscience.org/library/papers/2293704PubMed
1319362784Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.Int J Radiat Oncol Biol Phys2009https://conductscience.org/library/papers/19362784PubMed
14889677Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.Br J Cancer1977https://conductscience.org/library/papers/889677PubMed
1518418278Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.Laryngoscope2008https://conductscience.org/library/papers/18418278PubMed
1618212229PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.AJR Am J Roentgenol2008https://conductscience.org/library/papers/18212229PubMed
1721609453Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy.Radiat Oncol2011https://conductscience.org/library/papers/21609453PubMed
1822196796Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results.Clin Oncol (R Coll Radiol)2012https://conductscience.org/library/papers/22196796PubMed
1912694833Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.Int J Radiat Oncol Biol Phys2003https://conductscience.org/library/papers/12694833PubMed
2017680220Locoregional failure analysis in head-and-neck cancer patients treated with IMRT.Strahlenther Onkol2007https://conductscience.org/library/papers/17680220PubMed

See all 28 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42073589Multicenter Study of Multimodal MRI Radiomics and Deep Learning-Based Segmentation for Predicting Local Recurrence of Nasopharyngeal Carcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/42073589PubMed
41459851Dosimetric Determinants of Locoregional Failure in Nasopharyngeal Carcinoma Treated with Definitive Intensity-modulated Radiotherapy (IMRT) with or without Concomitant Chemotherapy.Asian Pac J Cancer Prev2025https://conductscience.org/library/papers/41459851PubMed
40197313Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial.BMC Cancer2025https://conductscience.org/library/papers/40197313PubMed
39335592Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy.Biomedicines2024https://conductscience.org/library/papers/39335592PubMed
39308690PD-1 Inhibitors Combined with Chemotherapy versus Re-irradiation/chemoradiotherapy for Unresectable Locally Recurrent T3-4 Nasopharyngeal Carcinoma: A Retrospective Study.J Cancer2024https://conductscience.org/library/papers/39308690PubMed
38480535Salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma in a non-endemic area.Eur Arch Otorhinolaryngol2024https://conductscience.org/library/papers/38480535PubMed
38169541Patterns and Prognosis of Local Recurrence of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy.J Cancer2024https://conductscience.org/library/papers/38169541PubMed
38153435Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?Strahlenther Onkol2024https://conductscience.org/library/papers/38153435PubMed
36944958Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation.Radiat Oncol2023https://conductscience.org/library/papers/36944958PubMed
36386526Reconstruction of nasopharyngeal defect with submental flap during surgery for nasopharyngeal malignant tumors.Front Surg2022https://conductscience.org/library/papers/36386526PubMed
35954458Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency.Cancers (Basel)2022https://conductscience.org/library/papers/35954458PubMed
35223448Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study.Front Oncol2021https://conductscience.org/library/papers/35223448PubMed
34699681The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.Cancer Commun (Lond)2021https://conductscience.org/library/papers/34699681PubMed
34556123A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.Radiat Oncol2021https://conductscience.org/library/papers/34556123PubMed
33955719Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives.Cancer Commun (Lond)2021https://conductscience.org/library/papers/33955719PubMed
33544302Convolutional neural network in nasopharyngeal carcinoma: how good is automatic delineation for primary tumor on a non-contrast-enhanced fat-suppressed T2-weighted MRI?Jpn J Radiol2021https://conductscience.org/library/papers/33544302PubMed
33204320Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.Theranostics2020https://conductscience.org/library/papers/33204320PubMed
33058559Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis.Cancer Med2020https://conductscience.org/library/papers/33058559PubMed
33017440Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy.PLoS One2020https://conductscience.org/library/papers/33017440PubMed
32337354Effect of relevant factors on radiation-induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.Laryngoscope Investig Otolaryngol2020https://conductscience.org/library/papers/32337354PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24674015

GET https://conductscience.org/api/papers/v1/24674015/references?page=2